Clinical trial Recruiting at 1 site Observational Ages 18 to 80

Salivary biomarkers in people with periodontitis and type 2 diabetes

Official title: Evaluation of Salivary Apelin, Chemerin, Ghrelin and Lipocalin 2 Levels in Diabetic Patients With Periodontitis

Run by Necmettin Erbakan University · NCT07703345 · Data updated 2026-11-12

This study tests whether saliva levels of apelin, chemerin, ghrelin, and lipocalin-2 differ across people with periodontitis, type 2 diabetes, both, or neither.

More Periodontitis trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment88 (estimated)
SponsorNecmettin Erbakan University
Academic / other
Locations1 site (Konya, Konya)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedAugust 1, 2026
Study endsAugust 1, 2026
Registry record updatedJuly 14, 2026
Trial IDNCT07703345 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 who visit the Necmettin Erbakan University periodontology clinic, have at least 20 teeth, and fall into one of four groups: periodontally healthy with/without type 2 diabetes or periodontitis with/without type 2 diabetes.

Probably not a fit

Participants with mild conditions or those not exhibiting biomarker differences may not obtain direct clinical benefits from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This cross-sectional observational study will measure specific salivary biomarkers in 88 participants divided into four groups based on periodontal health and diabetes status. Calibrated clinicians will assess periodontal parameters and collect unstimulated saliva before any periodontal treatment. Biomarker levels will be quantified using ELISA assays to explore associations with periodontal disease, diabetes, and clinical measures of periodontitis. The work will be conducted at the Necmettin Erbakan University Department of Periodontology, enrolling adults aged 18 to 80 who meet the eligibility criteria.

Why it matters

Potential benefit: Findings could help identify salivary biomarkers that reflect periodontal and metabolic health, potentially guiding future diagnostics or risk stratification.

How similar studies have gone: Previous research has shown associations between salivary biomarkers and periodontal/metabolic conditions, but this specific four-group cross-sectional approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals aged 18 to 80 years. Individuals who apply to the Department of Periodontology, Faculty of Dentistry, Necmettin Erbakan University.

Individuals who agree to participate in the study and sign the informed consent form.

Presence of at least 20 teeth. For the periodontally healthy groups: diagnosis of periodontal health based on routine clinical and radiographic examination.

For the periodontitis groups: diagnosis of generalized Stage II or Stage III periodontitis based on routine clinical and radiographic examination according to the 2017 World Workshop Classification of Periodontal and Peri-Implant Diseases and Conditions.

For the type 2 diabetes mellitus groups: diagnosis of type 2 diabetes mellitus. For the systemically healthy groups: absence of systemic diseases, including type 2 diabetes mellitus.

Exclusion Criteria:

* Periodontal treatment, including scaling and root surface debridement, within the last 6 months.

Antibiotic use within the last 6 months. Pregnancy or lactation. Presence of autoimmune diseases such as rheumatoid arthritis, familial Mediterranean fever, ankylosing spondylitis, Behçet disease, or psoriasis.

Presence of systemic diseases other than type 2 diabetes mellitus in the diabetes groups.

Presence of systemic diseases such as nephrotic syndrome, chronic renal disease, or cardiovascular disease.

Smoking 10 or more cigarettes per day.

Where it's running

  • Necmettin Erbakan University Faculty of Dentistry, Department of Periodontology
    Konya, Konya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.